A leading precision medicine company focused on cancer detection and testing. The company has revenues of over USD500 million.
After publishing an inaugural ESG report in 2023, the client required support in enhancing ESG across the business, including conducting a greenhouse gas emissions inventory, understanding external ESG ratings, navigating the evolving ESG landscape, and meeting ongoing stakeholder requests. They did not want to develop their teams in-house and wanted to run this as a managed service.

Conducting a comprehensive greenhouse gas emissions inventory across Scope 1, 2, and 3 categories and submission of the client's first response to CDP.

Evaluating ESG ratings from agencies such as MSCI, ISS ESG, EcoVadis, and Sustainalytics and identifying potential gaps and areas for improvement.

Strategic planning, project management, and authoring of interim ESG updates to showcase ongoing progress.

Establishing guidelines for responsible practices across the supply chain, including drafting a supplier code of conduct.

Supporting the client to understand investor expectations better and address any requests from stakeholders both internally and externally.

Continuously supporting the client in navigating the evolving ESG regulation landscape.
This will close in 0 seconds
